Share Price and Basic Stock Data
Last Updated: December 13, 2025, 12:57 am
| PEG Ratio | 1.21 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Gillanders Arbuthnot & Company Ltd operates primarily in the plantations sector, focusing on tea and coffee production. The company’s recent revenue trajectory shows some volatility, with reported sales of ₹449 Cr for FY 2023, a slight increase from ₹406 Cr in FY 2022. However, the subsequent fiscal year (FY 2024) saw a decline to ₹363 Cr, indicating challenges in maintaining sales momentum. The trailing twelve months (TTM) figure currently stands at ₹447 Cr, suggesting a potential recovery as the company navigates through operational hurdles. Quarterly sales reflect this inconsistency, with the highest sales in September 2023 at ₹105.42 Cr, while a notable dip to ₹68.75 Cr was recorded in March 2024. These fluctuations may stem from external factors such as weather conditions impacting tea and coffee yields, as well as changing market dynamics.
Profitability and Efficiency Metrics
Profitability metrics for Gillanders Arbuthnot reveal a mixed performance. The operating profit margin (OPM) has shown significant variability, with a negative OPM of -21.47% in March 2023 contrasting sharply with a positive 19.95% in September 2024. The company recorded a net profit of ₹31 Cr for FY 2023, a notable recovery from losses in previous quarters, but the margins remain under pressure. The return on equity (ROE) stands at a modest 6.83%, while the return on capital employed (ROCE) is slightly lower at 6.80%. These figures indicate that while the company is generating returns, they are not particularly strong compared to industry benchmarks. The interest coverage ratio (ICR) of 2.93x reflects a comfortable ability to service debt, but the overall profitability metrics suggest the need for operational efficiency improvements to enhance margins.
Balance Sheet Strength and Financial Ratios
The balance sheet of Gillanders Arbuthnot appears stable, with total borrowings recorded at ₹147 Cr against reserves of ₹234 Cr, providing a solid buffer. The debt-to-equity ratio stands at 0.51x, indicating a moderate level of leverage that is manageable. The company’s current ratio of 0.96x suggests it is on the verge of being able to cover its short-term liabilities, which is a slight concern. Additionally, the price-to-book value ratio is at 0.83x, indicating that the stock is trading below its book value, potentially presenting a value opportunity for investors. However, the cash conversion cycle (CCC) of 146 days is a point of caution, as it reflects longer periods in collecting receivables and managing inventory, which can tie up precious capital and impact liquidity.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Gillanders Arbuthnot reveals a strong promoter presence, with promoters holding 69.05% of the shares. This high level of insider ownership can be a positive indicator of alignment with shareholder interests. However, foreign institutional investors (FIIs) have shown no interest, holding 0.00% of the shares, while domestic institutional investors (DIIs) account for a meager 0.31%. The public holds a significant 30.60%, suggesting a diversified retail base. The number of shareholders has fluctuated, reaching 10,245 recently, which indicates some level of investor interest. Nonetheless, the lack of institutional backing may raise concerns regarding the stock’s perceived stability and growth potential in the eyes of larger investors.
Outlook, Risks, and Final Insight
Looking ahead, Gillanders Arbuthnot faces a dual-edged sword of opportunities and risks. On one hand, the recovery in net profits and the ability to manage borrowings effectively could signal a turnaround. However, the company must address its profitability challenges and improve operational efficiency to sustain growth. External factors such as climate change, market demand fluctuations, and global commodity prices will play crucial roles in shaping the company’s future performance. Investors should remain cautious, as the absence of institutional interest may limit liquidity and price support. Therefore, while the stock may present potential value, it is essential for investors to weigh the operational risks against the prospect of recovery in profitability and stability in cash flows.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Goodricke Group Ltd | 369 Cr. | 171 | 295/162 | 149 | 0.00 % | 3.22 % | 2.86 % | 10.0 | |
| Diana Tea Company Ltd | 42.7 Cr. | 28.5 | 43.8/26.0 | 47.3 | 0.00 % | 1.40 % | 7.16 % | 5.00 | |
| Bengal Tea & Fabrics Ltd | 126 Cr. | 140 | 189/126 | 24.6 | 223 | 1.07 % | 5.22 % | 55.3 % | 10.0 |
| Bansisons Tea Industries Ltd | 8.62 Cr. | 13.6 | 13.6/5.60 | 9.42 | 0.00 % | 1.01 % | 1.01 % | 10.0 | |
| B&A Ltd | 121 Cr. | 391 | 689/354 | 12.9 | 528 | 0.00 % | 8.96 % | 6.02 % | 10.0 |
| Industry Average | 8,860.88 Cr | 403.01 | 71.27 | 265.00 | 0.42% | 7.88% | 16.74% | 7.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 124.81 | 143.56 | 103.24 | 77.42 | 87.68 | 105.42 | 101.43 | 68.75 | 84.85 | 126.75 | 127.64 | 103.94 | 88.37 |
| Expenses | 121.76 | 119.46 | 101.82 | 94.04 | 90.30 | 96.42 | 125.76 | 84.41 | 90.11 | 101.46 | 119.87 | 106.03 | 88.49 |
| Operating Profit | 3.05 | 24.10 | 1.42 | -16.62 | -2.62 | 9.00 | -24.33 | -15.66 | -5.26 | 25.29 | 7.77 | -2.09 | -0.12 |
| OPM % | 2.44% | 16.79% | 1.38% | -21.47% | -2.99% | 8.54% | -23.99% | -22.78% | -6.20% | 19.95% | 6.09% | -2.01% | -0.14% |
| Other Income | 12.60 | 3.91 | 6.07 | 7.67 | 4.59 | 1.86 | 8.25 | -1.07 | 1.74 | 3.53 | 13.23 | 3.99 | 0.49 |
| Interest | 5.24 | 4.39 | 3.99 | 4.42 | 3.98 | 3.51 | 3.94 | 2.86 | 3.46 | 2.85 | 2.95 | 3.10 | 3.24 |
| Depreciation | 2.95 | 3.09 | 3.01 | 2.91 | 3.03 | 3.15 | 2.86 | 2.72 | 2.67 | 2.78 | 2.80 | 2.61 | 2.65 |
| Profit before tax | 7.46 | 20.53 | 0.49 | -16.28 | -5.04 | 4.20 | -22.88 | -22.31 | -9.65 | 23.19 | 15.25 | -3.81 | -5.52 |
| Tax % | 8.58% | 11.89% | -51.02% | -33.54% | 4.37% | 13.33% | -2.32% | 10.49% | 1.76% | 7.37% | 14.56% | -153.54% | -1.27% |
| Net Profit | 6.81 | 18.09 | 0.74 | -10.81 | -5.26 | 3.64 | -22.35 | -24.65 | -9.82 | 21.47 | 13.03 | 2.04 | -5.46 |
| EPS in Rs | 3.19 | 8.48 | 0.35 | -5.07 | -2.46 | 1.71 | -10.47 | -11.55 | -4.60 | 10.06 | 6.11 | 0.96 | -2.56 |
Last Updated: August 20, 2025, 10:30 am
Below is a detailed analysis of the quarterly data for Gillanders Arbuthnot & Company Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 88.37 Cr.. The value appears to be declining and may need further review. It has decreased from 103.94 Cr. (Mar 2025) to 88.37 Cr., marking a decrease of 15.57 Cr..
- For Expenses, as of Jun 2025, the value is 88.49 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 106.03 Cr. (Mar 2025) to 88.49 Cr., marking a decrease of 17.54 Cr..
- For Operating Profit, as of Jun 2025, the value is -0.12 Cr.. The value appears strong and on an upward trend. It has increased from -2.09 Cr. (Mar 2025) to -0.12 Cr., marking an increase of 1.97 Cr..
- For OPM %, as of Jun 2025, the value is -0.14%. The value appears strong and on an upward trend. It has increased from -2.01% (Mar 2025) to -0.14%, marking an increase of 1.87%.
- For Other Income, as of Jun 2025, the value is 0.49 Cr.. The value appears to be declining and may need further review. It has decreased from 3.99 Cr. (Mar 2025) to 0.49 Cr., marking a decrease of 3.50 Cr..
- For Interest, as of Jun 2025, the value is 3.24 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.10 Cr. (Mar 2025) to 3.24 Cr., marking an increase of 0.14 Cr..
- For Depreciation, as of Jun 2025, the value is 2.65 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.61 Cr. (Mar 2025) to 2.65 Cr., marking an increase of 0.04 Cr..
- For Profit before tax, as of Jun 2025, the value is -5.52 Cr.. The value appears to be declining and may need further review. It has decreased from -3.81 Cr. (Mar 2025) to -5.52 Cr., marking a decrease of 1.71 Cr..
- For Tax %, as of Jun 2025, the value is -1.27%. The value appears to be increasing, which may not be favorable. It has increased from -153.54% (Mar 2025) to -1.27%, marking an increase of 152.27%.
- For Net Profit, as of Jun 2025, the value is -5.46 Cr.. The value appears to be declining and may need further review. It has decreased from 2.04 Cr. (Mar 2025) to -5.46 Cr., marking a decrease of 7.50 Cr..
- For EPS in Rs, as of Jun 2025, the value is -2.56. The value appears to be declining and may need further review. It has decreased from 0.96 (Mar 2025) to -2.56, marking a decrease of 3.52.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 5:19 am
| Metric | Mar 2007 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 355 | 863 | 817 | 681 | 665 | 751 | 660 | 431 | 406 | 449 | 363 | 443 | 447 |
| Expenses | 333 | 821 | 812 | 653 | 615 | 686 | 632 | 400 | 377 | 437 | 397 | 417 | 416 |
| Operating Profit | 22 | 42 | 5 | 28 | 50 | 65 | 28 | 31 | 30 | 12 | -34 | 26 | 31 |
| OPM % | 6% | 5% | 1% | 4% | 7% | 9% | 4% | 7% | 7% | 3% | -9% | 6% | 7% |
| Other Income | 11 | 9 | 12 | 30 | 21 | 12 | 26 | 7 | 17 | 30 | 14 | 22 | 21 |
| Interest | 10 | 42 | 51 | 54 | 50 | 50 | 48 | 37 | 23 | 18 | 14 | 12 | 12 |
| Depreciation | 9 | 21 | 19 | 22 | 24 | 20 | 20 | 16 | 12 | 12 | 12 | 11 | 11 |
| Profit before tax | 14 | -12 | -53 | -18 | -4 | 7 | -12 | -15 | 11 | 12 | -46 | 25 | 29 |
| Tax % | 21% | -27% | 4% | 4% | 112% | 95% | 22% | 2% | -42% | -22% | 6% | -7% | |
| Net Profit | 11 | -9 | -55 | -19 | -9 | 0 | -15 | -16 | 16 | 15 | -49 | 27 | 31 |
| EPS in Rs | 6.69 | -4.16 | -25.93 | -8.83 | -4.02 | 0.15 | -7.13 | -7.32 | 7.66 | 6.94 | -22.78 | 12.52 | 14.57 |
| Dividend Payout % | 25% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -511.11% | 65.45% | 52.63% | 100.00% | -6.67% | 200.00% | -6.25% | -426.67% | 155.10% |
| Change in YoY Net Profit Growth (%) | 0.00% | 576.57% | -12.82% | 47.37% | -106.67% | 206.67% | -206.25% | -420.42% | 581.77% |
Gillanders Arbuthnot & Company Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2015-2016 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -6% |
| 5 Years: | -8% |
| 3 Years: | 3% |
| TTM: | 24% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 21% |
| 3 Years: | 0% |
| TTM: | 139% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 34% |
| 3 Years: | 21% |
| 1 Year: | 42% |
| Return on Equity | |
|---|---|
| 10 Years: | -6% |
| 5 Years: | -2% |
| 3 Years: | -4% |
| Last Year: | 7% |
Last Updated: September 5, 2025, 4:45 am
Balance Sheet
Last Updated: December 4, 2025, 1:17 am
| Month | Mar 2007 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 11 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 |
| Reserves | 107 | 266 | 155 | 262 | 271 | 268 | 255 | 231 | 248 | 255 | 196 | 224 | 234 |
| Borrowings | 91 | 456 | 480 | 449 | 424 | 392 | 366 | 227 | 183 | 145 | 129 | 139 | 147 |
| Other Liabilities | 72 | 242 | 209 | 203 | 225 | 244 | 214 | 145 | 144 | 129 | 130 | 130 | 128 |
| Total Liabilities | 281 | 985 | 865 | 936 | 942 | 925 | 857 | 624 | 597 | 550 | 477 | 514 | 530 |
| Fixed Assets | 112 | 421 | 310 | 441 | 432 | 427 | 421 | 315 | 312 | 298 | 263 | 256 | 253 |
| CWIP | 10 | 11 | 4 | 9 | 17 | 14 | 15 | 14 | 12 | 11 | 9 | 13 | 16 |
| Investments | 13 | 28 | 28 | 29 | 34 | 29 | 17 | 8 | 3 | 0 | 0 | 0 | 0 |
| Other Assets | 145 | 525 | 522 | 457 | 460 | 454 | 404 | 287 | 271 | 241 | 205 | 245 | 260 |
| Total Assets | 281 | 985 | 865 | 936 | 942 | 925 | 857 | 624 | 597 | 550 | 477 | 514 | 530 |
Below is a detailed analysis of the balance sheet data for Gillanders Arbuthnot & Company Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 21.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 21.00 Cr..
- For Reserves, as of Sep 2025, the value is 234.00 Cr.. The value appears strong and on an upward trend. It has increased from 224.00 Cr. (Mar 2025) to 234.00 Cr., marking an increase of 10.00 Cr..
- For Borrowings, as of Sep 2025, the value is 147.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 139.00 Cr. (Mar 2025) to 147.00 Cr., marking an increase of 8.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 128.00 Cr.. The value appears to be improving (decreasing). It has decreased from 130.00 Cr. (Mar 2025) to 128.00 Cr., marking a decrease of 2.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 530.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 514.00 Cr. (Mar 2025) to 530.00 Cr., marking an increase of 16.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 253.00 Cr.. The value appears to be declining and may need further review. It has decreased from 256.00 Cr. (Mar 2025) to 253.00 Cr., marking a decrease of 3.00 Cr..
- For CWIP, as of Sep 2025, the value is 16.00 Cr.. The value appears strong and on an upward trend. It has increased from 13.00 Cr. (Mar 2025) to 16.00 Cr., marking an increase of 3.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 260.00 Cr.. The value appears strong and on an upward trend. It has increased from 245.00 Cr. (Mar 2025) to 260.00 Cr., marking an increase of 15.00 Cr..
- For Total Assets, as of Sep 2025, the value is 530.00 Cr.. The value appears strong and on an upward trend. It has increased from 514.00 Cr. (Mar 2025) to 530.00 Cr., marking an increase of 16.00 Cr..
Notably, the Reserves (234.00 Cr.) exceed the Borrowings (147.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2007 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -69.00 | -414.00 | -475.00 | -421.00 | -374.00 | -327.00 | -338.00 | -196.00 | -153.00 | -133.00 | -163.00 | -113.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2007 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 26 | 56 | 57 | 54 | 53 | 47 | 45 | 54 | 36 | 21 | 29 | 51 |
| Inventory Days | 130 | 135 | 156 | 207 | 253 | 219 | 206 | 240 | 389 | 287 | 314 | 225 |
| Days Payable | 97 | 92 | 112 | 148 | 180 | 166 | 164 | 163 | 220 | 129 | 164 | 130 |
| Cash Conversion Cycle | 59 | 99 | 101 | 113 | 126 | 100 | 87 | 130 | 204 | 179 | 180 | 146 |
| Working Capital Days | 72 | -21 | 1 | -6 | -24 | -25 | -47 | -11 | 2 | -1 | -11 | -7 |
| ROCE % | 10% | -0% | 1% | 6% | 8% | 4% | 4% | 7% | 4% | -8% | 7% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 12.52 | -22.78 | 6.95 | 7.66 | -7.32 |
| Diluted EPS (Rs.) | 12.52 | -22.78 | 6.95 | 7.66 | -7.32 |
| Cash EPS (Rs.) | 17.61 | -17.27 | 12.55 | 13.49 | 0.19 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 114.88 | 101.89 | 129.69 | 126.44 | 118.37 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 114.88 | 101.89 | 129.69 | 126.44 | 118.37 |
| Revenue From Operations / Share (Rs.) | 207.65 | 170.22 | 210.39 | 190.42 | 201.83 |
| PBDIT / Share (Rs.) | 16.98 | -9.36 | 14.78 | 22.12 | 18.70 |
| PBIT / Share (Rs.) | 11.89 | -14.87 | 9.18 | 16.29 | 11.19 |
| PBT / Share (Rs.) | 11.70 | -21.56 | 5.71 | 5.38 | -7.15 |
| Net Profit / Share (Rs.) | 12.52 | -22.78 | 6.95 | 7.66 | -7.32 |
| NP After MI And SOA / Share (Rs.) | 12.52 | -22.78 | 6.95 | 7.66 | -7.32 |
| PBDIT Margin (%) | 8.17 | -5.50 | 7.02 | 11.61 | 9.26 |
| PBIT Margin (%) | 5.72 | -8.73 | 4.36 | 8.55 | 5.54 |
| PBT Margin (%) | 5.63 | -12.66 | 2.71 | 2.82 | -3.54 |
| Net Profit Margin (%) | 6.02 | -13.38 | 3.30 | 4.02 | -3.62 |
| NP After MI And SOA Margin (%) | 6.02 | -13.38 | 3.30 | 4.02 | -3.62 |
| Return on Networth / Equity (%) | 10.89 | -22.35 | 5.35 | 6.05 | -6.18 |
| Return on Capital Employeed (%) | 8.60 | -12.43 | 6.06 | 9.99 | 6.96 |
| Return On Assets (%) | 5.19 | -10.19 | 2.69 | 2.73 | -2.50 |
| Long Term Debt / Equity (X) | 0.05 | 0.08 | 0.09 | 0.21 | 0.30 |
| Total Debt / Equity (X) | 0.51 | 0.53 | 0.47 | 0.63 | 0.73 |
| Asset Turnover Ratio (%) | 0.89 | 0.70 | 0.78 | 0.64 | 0.56 |
| Current Ratio (X) | 0.96 | 0.85 | 1.01 | 1.03 | 0.99 |
| Quick Ratio (X) | 0.45 | 0.36 | 0.47 | 0.50 | 0.61 |
| Inventory Turnover Ratio (X) | 0.46 | 0.52 | 0.78 | 0.95 | 0.57 |
| Interest Coverage Ratio (X) | 2.93 | -1.40 | 1.75 | 2.03 | 1.08 |
| Interest Coverage Ratio (Post Tax) (X) | 2.20 | -2.41 | 1.23 | 1.70 | 0.63 |
| Enterprise Value (Cr.) | 343.60 | 282.86 | 273.58 | 318.10 | 271.78 |
| EV / Net Operating Revenue (X) | 0.77 | 0.77 | 0.60 | 0.78 | 0.63 |
| EV / EBITDA (X) | 9.48 | -14.15 | 8.67 | 6.74 | 6.81 |
| MarketCap / Net Operating Revenue (X) | 0.46 | 0.43 | 0.29 | 0.34 | 0.21 |
| Price / BV (X) | 0.83 | 0.71 | 0.47 | 0.51 | 0.36 |
| Price / Net Operating Revenue (X) | 0.46 | 0.43 | 0.29 | 0.34 | 0.21 |
| EarningsYield | 0.13 | -0.31 | 0.11 | 0.11 | -0.16 |
After reviewing the key financial ratios for Gillanders Arbuthnot & Company Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 12.52. This value is within the healthy range. It has increased from -22.78 (Mar 24) to 12.52, marking an increase of 35.30.
- For Diluted EPS (Rs.), as of Mar 25, the value is 12.52. This value is within the healthy range. It has increased from -22.78 (Mar 24) to 12.52, marking an increase of 35.30.
- For Cash EPS (Rs.), as of Mar 25, the value is 17.61. This value is within the healthy range. It has increased from -17.27 (Mar 24) to 17.61, marking an increase of 34.88.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 114.88. It has increased from 101.89 (Mar 24) to 114.88, marking an increase of 12.99.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 114.88. It has increased from 101.89 (Mar 24) to 114.88, marking an increase of 12.99.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 207.65. It has increased from 170.22 (Mar 24) to 207.65, marking an increase of 37.43.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 16.98. This value is within the healthy range. It has increased from -9.36 (Mar 24) to 16.98, marking an increase of 26.34.
- For PBIT / Share (Rs.), as of Mar 25, the value is 11.89. This value is within the healthy range. It has increased from -14.87 (Mar 24) to 11.89, marking an increase of 26.76.
- For PBT / Share (Rs.), as of Mar 25, the value is 11.70. This value is within the healthy range. It has increased from -21.56 (Mar 24) to 11.70, marking an increase of 33.26.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 12.52. This value is within the healthy range. It has increased from -22.78 (Mar 24) to 12.52, marking an increase of 35.30.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 12.52. This value is within the healthy range. It has increased from -22.78 (Mar 24) to 12.52, marking an increase of 35.30.
- For PBDIT Margin (%), as of Mar 25, the value is 8.17. This value is below the healthy minimum of 10. It has increased from -5.50 (Mar 24) to 8.17, marking an increase of 13.67.
- For PBIT Margin (%), as of Mar 25, the value is 5.72. This value is below the healthy minimum of 10. It has increased from -8.73 (Mar 24) to 5.72, marking an increase of 14.45.
- For PBT Margin (%), as of Mar 25, the value is 5.63. This value is below the healthy minimum of 10. It has increased from -12.66 (Mar 24) to 5.63, marking an increase of 18.29.
- For Net Profit Margin (%), as of Mar 25, the value is 6.02. This value is within the healthy range. It has increased from -13.38 (Mar 24) to 6.02, marking an increase of 19.40.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.02. This value is below the healthy minimum of 8. It has increased from -13.38 (Mar 24) to 6.02, marking an increase of 19.40.
- For Return on Networth / Equity (%), as of Mar 25, the value is 10.89. This value is below the healthy minimum of 15. It has increased from -22.35 (Mar 24) to 10.89, marking an increase of 33.24.
- For Return on Capital Employeed (%), as of Mar 25, the value is 8.60. This value is below the healthy minimum of 10. It has increased from -12.43 (Mar 24) to 8.60, marking an increase of 21.03.
- For Return On Assets (%), as of Mar 25, the value is 5.19. This value is within the healthy range. It has increased from -10.19 (Mar 24) to 5.19, marking an increase of 15.38.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 0.2. It has decreased from 0.08 (Mar 24) to 0.05, marking a decrease of 0.03.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.51. This value is within the healthy range. It has decreased from 0.53 (Mar 24) to 0.51, marking a decrease of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.89. It has increased from 0.70 (Mar 24) to 0.89, marking an increase of 0.19.
- For Current Ratio (X), as of Mar 25, the value is 0.96. This value is below the healthy minimum of 1.5. It has increased from 0.85 (Mar 24) to 0.96, marking an increase of 0.11.
- For Quick Ratio (X), as of Mar 25, the value is 0.45. This value is below the healthy minimum of 1. It has increased from 0.36 (Mar 24) to 0.45, marking an increase of 0.09.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.46. This value is below the healthy minimum of 4. It has decreased from 0.52 (Mar 24) to 0.46, marking a decrease of 0.06.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 2.93. This value is below the healthy minimum of 3. It has increased from -1.40 (Mar 24) to 2.93, marking an increase of 4.33.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.20. This value is below the healthy minimum of 3. It has increased from -2.41 (Mar 24) to 2.20, marking an increase of 4.61.
- For Enterprise Value (Cr.), as of Mar 25, the value is 343.60. It has increased from 282.86 (Mar 24) to 343.60, marking an increase of 60.74.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.77. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.77.
- For EV / EBITDA (X), as of Mar 25, the value is 9.48. This value is within the healthy range. It has increased from -14.15 (Mar 24) to 9.48, marking an increase of 23.63.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.46. This value is below the healthy minimum of 1. It has increased from 0.43 (Mar 24) to 0.46, marking an increase of 0.03.
- For Price / BV (X), as of Mar 25, the value is 0.83. This value is below the healthy minimum of 1. It has increased from 0.71 (Mar 24) to 0.83, marking an increase of 0.12.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.46. This value is below the healthy minimum of 1. It has increased from 0.43 (Mar 24) to 0.46, marking an increase of 0.03.
- For EarningsYield, as of Mar 25, the value is 0.13. This value is below the healthy minimum of 5. It has increased from -0.31 (Mar 24) to 0.13, marking an increase of 0.44.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Gillanders Arbuthnot & Company Ltd:
- Net Profit Margin: 6.02%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 8.6% (Industry Average ROCE: 7.88%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 10.89% (Industry Average ROE: 16.74%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.2
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.45
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 16.6 (Industry average Stock P/E: 71.27)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.51
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 6.02%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Plantations - Tea & Coffee | C-4, Gillander House, Netaji Subhas Road Kolkata West Bengal 700001 | secretarial@gillandersarbuthnot.com http://www.gillandersarbuthnot.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Arun Kumar Kothari | Chairman |
| Mr. Mahesh Sodhani | Managing Director & CEO |
| Mrs. Prabhawati Devi Kothari | Non Executive Director |
| Mr. Arvind Baheti | Independent Director |
| Mr. Charudatta Raghvendra Prayag | Independent Director |
| Mr. Kothaneth Ashok | Independent Director |
FAQ
What is the intrinsic value of Gillanders Arbuthnot & Company Ltd?
Gillanders Arbuthnot & Company Ltd's intrinsic value (as of 13 December 2025) is 111.02 which is 3.76% higher the current market price of 107.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 228 Cr. market cap, FY2025-2026 high/low of 152/91.6, reserves of ₹234 Cr, and liabilities of 530 Cr.
What is the Market Cap of Gillanders Arbuthnot & Company Ltd?
The Market Cap of Gillanders Arbuthnot & Company Ltd is 228 Cr..
What is the current Stock Price of Gillanders Arbuthnot & Company Ltd as on 13 December 2025?
The current stock price of Gillanders Arbuthnot & Company Ltd as on 13 December 2025 is 107.
What is the High / Low of Gillanders Arbuthnot & Company Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Gillanders Arbuthnot & Company Ltd stocks is 152/91.6.
What is the Stock P/E of Gillanders Arbuthnot & Company Ltd?
The Stock P/E of Gillanders Arbuthnot & Company Ltd is 16.6.
What is the Book Value of Gillanders Arbuthnot & Company Ltd?
The Book Value of Gillanders Arbuthnot & Company Ltd is 120.
What is the Dividend Yield of Gillanders Arbuthnot & Company Ltd?
The Dividend Yield of Gillanders Arbuthnot & Company Ltd is 0.00 %.
What is the ROCE of Gillanders Arbuthnot & Company Ltd?
The ROCE of Gillanders Arbuthnot & Company Ltd is 6.80 %.
What is the ROE of Gillanders Arbuthnot & Company Ltd?
The ROE of Gillanders Arbuthnot & Company Ltd is 6.83 %.
What is the Face Value of Gillanders Arbuthnot & Company Ltd?
The Face Value of Gillanders Arbuthnot & Company Ltd is 10.0.